Parallax Volatility Advisers
ARRY

Parallax Volatility Advisers’s Array Biopharma Inc ARRY Stock Holding History

Parallax Volatility Advisers’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-42
Closed -$2K – 3921
2019
Q2 		$2K Sell
42
-6,075
-99% -$171K ﹤0.01% 2408
2019
Q1 		$149K Buy
6,117
+5,823
+1,981% +$121K ﹤0.01% 2007
2018
Q4 		$4K Buy
+294
New +$4.46K ﹤0.01% 2610
2018
Q1 		– Sell
-142,019
Closed -$1.82M – 5088
2017
Q4 		$1.82M Buy
+142,019
New +$1.62M ﹤0.01% 950
2016
Q4 		– Sell
-18,715
Closed -$126K – 4562
2016
Q3 		$126K Sell
18,715
-163,524
-90% -$632K ﹤0.01% 2026
2016
Q2 		$649K Sell
182,239
-589,654
-76% -$1.92M ﹤0.01% 1357
2016
Q1 		$2.28M Buy
771,893
+181,451
+31% +$544K 0.01% 865
2015
Q4 		$2.49M Buy
590,442
+531,386
+900% +$2.43M 0.01% 936
2015
Q3 		$269K Buy
59,056
+9,056
+18% +$53.7K ﹤0.01% 1728
2015
Q2 		$361K Buy
+50,000
New +$369K ﹤0.01% 1775

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Parallax Volatility Advisers's ARRY Position: Q3 2019 in Review

Parallax Volatility Advisers sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 42 shares — an estimated $2K sold.

Parallax Volatility Advisers first reported a position in ARRY in Q2 2015 and held it in 10 quarters. The position peaked at $2.49M in Q4 2015. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Parallax Volatility Advisers reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Parallax Volatility Advisers sold 42 Array Biopharma Inc shares in Q3 2019, an estimated $2K.
  • Parallax Volatility Advisers first reported a position in Array Biopharma Inc in Q2 2015 and held it in 10 quarters.
  • Parallax Volatility Advisers's Array Biopharma Inc position peaked at $2.49M in Q4 2015.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Parallax Volatility Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.